Below are the most recent publications written about "Indomethacin" by people in Profiles.
-
Kaluarachchi DC, Rysavy MA, Carper BA, Chock VY, Laughon MM, Backes CH, Colaizy TT, Bell EF, McNamara PJ. Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 2024 Mar; 266:113877.
-
Chawla S, Natarajan G, Laptook AR, Chowdhury D, Bell EF, Ambalavanan N, Carlo WA, Gantz M, Das A, Tapia JL, Harmon HM, Shankaran S. Model for severe intracranial hemorrhage and role of early indomethacin in extreme preterm infants. Pediatr Res. 2022 12; 92(6):1648-1656.
-
Parvin N, Charlton JR, Baldelomar EJ, Derakhshan JJ, Bennett KM. Mapping vascular and glomerular pathology in a rabbit model of neonatal acute kidney injury using MRI. Anat Rec (Hoboken). 2020 10; 303(10):2716-2728.
-
Charlton JR, Baldelomar EJ, deRonde KA, Cathro HP, Charlton NP, Criswell SJ, Hyatt DM, Nam S, Pearl V, Bennett KM. Nephron loss detected by MRI following neonatal acute kidney injury in rabbits. Pediatr Res. 2020 06; 87(7):1185-1192.
-
Boghossian NS, Do BT, Bell EF, Dagle JM, Brumbaugh JE, Stoll BJ, Vohr BR, Das A, Shankaran S, Sanchez PJ, Wyckoff MH, Bethany Ball M. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants. Early Hum Dev. 2017 10; 113:10-17.
-
Kelleher J, Salas AA, Bhat R, Ambalavanan N, Saha S, Stoll BJ, Bell EF, Walsh MC, Laptook AR, S?nchez PJ, Shankaran S, VanMeurs KP, Hale EC, Newman NS, Ball MB, Das A, Higgins RD, Peralta-Carcelen M, Carlo WA. Prophylactic indomethacin and intestinal perforation in extremely low birth weight infants. Pediatrics. 2014 Nov; 134(5):e1369-77.
-
Flores FX, Ojeda FJ, Calhoun DA. Bartter syndrome: presentation in an extremely premature neonate. J Perinatol. 2013 Aug; 33(8):661-2.
-
Wadhawan R, Oh W, Vohr BR, Saha S, Das A, Bell EF, Laptook A, Shankaran S, Stoll BJ, Walsh MC, Higgins R. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18-22 months corrected age. Arch Dis Child Fetal Neonatal Ed. 2013 Mar; 98(2):F127-32.
-
Zhang Q, Ma P, Cole RB, Wang G. In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes. Eur J Pharm Sci. 2010 Sep 11; 41(1):163-72.
-
Konkle ME, Hargrove TY, Kleshchenko YY, von Kries JP, Ridenour W, Uddin MJ, Caprioli RM, Marnett LJ, Nes WD, Villalta F, Waterman MR, Lepesheva GI. Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase. J Med Chem. 2009 May 14; 52(9):2846-53.